Hazer lifts 11% amid the ASX hydrogen share reaching a construction milestone

What caused the Hazer share price to pop on Tuesday?

| More on:
a man in a hardhat inspects equipment in a processing plant looking towards the camera with a small smile with his hand on the machinery.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Hazer shares accelerated more than 11% today to 61 cents each
  • The company advised it has completed construction and commissioning activities at its Commercial Demonstration Project (CDP)
  • The CDP aims to produce low emission and cost-effective clean hydrogen

The Hazer Group Ltd (ASX: HZR) share price closed higher on Tuesday.

This comes after the hydrogen producer announced a construction milestone at its Commercial Demonstration Project (CDP).

Hazer's CDP is located at the Woodman Point Water Recovery Facility in Western Australia. The company aims to convert natural gas and similar methane feedstocks into hydrogen and high-quality graphite, using iron ore as a process catalyst.

Hazer shares reached an intraday high of 63 cents apiece today before closing 11.11% higher at 61 cents a share.

What's drovie the Hazer share price higher?

Investors bid the Hazer share price up following the company's latest positive announcement.

In a statement to the ASX, Hazer advised it has completed construction and the associated commissioning activities at its CDP.

The newly-built facility is the first fully-integrated demonstration of the company's Hazer Process. It will process biogas produced from the treatment of wastewater at the Woodman Point Water Recovery Facility to produce hydrogen and graphite.

Management noted that the CDP is a stepping stone in demonstrating the scale-up and commercial potential of the Hazer technology.

The latter is a leading example of methane pyrolysis, a low emission and cost-effective method to produce clean hydrogen.

The first phase of the testing program will be carried out at low temperatures using a temporary carbon steel reactor. This will allow trialling of the gas conditioning, solids handling, process control, safety, and utilities systems.

In addition, collection of the initial process data is expected to ultimately de-risk the full operation of the CDP.

However, the company is facing COVID-19-related disruptions to global supply chains in sourcing necessary equipment. As such, the hot-wall Hazer reactor is progressing at its manufacturing mill in China. This is expected to be delivered to Australia some time in the third quarter of 2022, with installation the following quarter.

Management commentary

Hazer Group CEO Geoff Ward touched on the significant achievement, saying:

We are delighted to have reached this important milestone.

I look forward to completing the testing program and continuing to demonstrate the capacity of the Hazer technology to play a significant role at large scale in achieving our critical global decarbonisation goals.

Despite today's gains, the Hazer share price has fallen 28% over the past 12 months and is down 47% year to date.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup
Share Gainers

Here are the top 10 ASX 200 shares today

It was a dour Tuesday for ASX investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »